Input images from the custom camera system are immediately analyzed for whitened precancerous lesions through the cerVIA Android application.
Preliminary testing of the cerVIA system has shown increased diagnostic sensitivity over conventional VIA testing.
The cerVIA system contours to standard speculums for simple image acquisition, seamlessly integrating into the VIA workflow to promote clinician adoption.
Through Luso Labs's inexpensive subscription-based pricing, clinicians can offer advanced cervical cancer screening at a lower price than competing tests.
Let's start talking
With a goal to reach patients within 3 years, our team welcomes feedback, collaborations and funding opportunities.